RMD · ResMed Inc.
$192.91
+1.76% last session
End-of-day data · updated 2026-07-24
Market cap
$28B
Enterprise value
$27B
Trailing P/E
18.5
Forward P/E
15.9
Dividend yield
1.0%
Beta
0.78
Avg volume
2M
Employees
11K
2D change
-0.53%
5D change
-3.57%
10D change
-0.58%
30D change
-2.35%
60D change
-7.77%
MTD change
-4.58%
YTD change
-19.91%
Analyst Outlook
Analyst estimates change daily — follow the shifts on the Estimate Trends page.
Technical Analysis
Analyst sentiment over time — RMD
Rec Mean (blue, left — higher = more bullish) vs. price targets (right).
Investment Bank Ratings as of 2026-07-15
Latest call per bank · past 12 months
Citigroup
Neutral$235
+21.8% vs priceJefferies
Hold$225
+16.6% vs priceRBC Capital
Outperform$276
+43.1% vs priceWells Fargo
Equal-Weight$225
+16.6% vs priceMorgan Stanley
Equal-Weight$230
+19.2% vs priceUBS
Buy$325
+68.5% vs priceRecent rating actions
| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| 2026-07-15 | Mizuho | Maintains | Outperform | $235 → $220 |
| 2026-07-13 | Citigroup | Downgrade | Buy → Neutral | $270 → $235 |
| 2026-07-10 | Jefferies | Maintains | Hold | $240 → $225 |
| 2026-07-08 | RBC Capital | Maintains | Outperform | $321 → $276 |
| 2026-07-08 | Wells Fargo | Maintains | Equal-Weight | $227 → $225 |
| 2026-06-22 | Keybanc | Maintains | Overweight | $290 → $266 |
| 2026-06-17 | Morgan Stanley | Downgrade | Overweight → Equal-Weight | $286 → $230 |
| 2026-06-15 | Citigroup | Maintains | Buy | $340 → $270 |
Ratings and price targets are the published opinions of the issuing banks, compiled from Yahoo Finance rating actions — not investment advice.
Signal Summary as of 2026-07-24
- RSI (14): RSI is 46 — neutral momentum, neither overbought nor oversold.
- Price vs 50-day MA: Trading 1.7% below the 50-day MA ($198.67).
- Price vs 200-day MA: Trading 16.1% below the 200-day MA ($232.83).
- MA cross: The 50-day MA sits below the 200-day MA (death-cross regime) — the longer-term trend points down.
- MACD (12,26,9): MACD histogram is negative (-1.14) — short-term momentum is fading.
- 52-week range: Price is within 10% of the 52-week low ($182.82).
RMD Price Chart
Loading chart for RMD…
Fundamentals
About ResMed Inc.
ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications to diagnose, treat, and manage respiratory disorders in the United States and internationally. The company operates in two segments, Sleep and Breathing Health, and Residential Care Software. It offers sleep recorders for the diagnosis and titration of sleep apnea in sleep clinics, hospitals, and at home, including ApneaLink Air, a portable diagnostic device that measures oximetry, respiratory effort, pulse, nasal flow, and snoring; NightOwl, a portable, cloud-connected, and disposable diagnostic device that measures AHI based on derived peripheral arterial tone, actigraphy, and oximetry; and EasyCare Tx, a sleep lab solution. The company also provides AirView, a cloud-based system that enables remote monitoring and changing of patients' device settings; myAir, a personalized therapy management application for patients with sleep apnea that provides support, education, and troubleshooting tools for increased patient engagement and improved compliance; and connectivity module which provides a cellular connection between compatible ventilation devices and AirView system. In addition, the company offers Brightree solutions which are solutions and services for organizations in home medical equipment and pharmacy, orthotic and prosthetic, and home infusion; HEALTHCAREfirst solutions that offers electronic health record, software, billing and coding services, and advanced analytics that enables home health and hospice agencies to optimize clinical, financial and administrative processes; MatrixCare EHR software as a service solutions used by skilled nursing and senior living providers, life plan communities, and home health and hospice sectors; and MEDIFOX DAN software solutions that is used by residential care providers, such as home health and nursing home providers. ResMed Inc. was founded in 1989 and is headquartered in San Diego, California.
More in Medical Instruments & Supplies
ISRG
Intuitive Surgical, Inc.
$119B -41.4% YTD
MDLN
Medline Inc.
$67B -10.4% YTD
BDX
Becton, Dickinson and Company
$42B 1.6% YTD
ALC
Alcon Inc.
$33B -14.3% YTD
WST
West Pharmaceutical Services, I
$25B 29.4% YTD
COO
The Cooper Companies, Inc.
$14B -14.3% YTD
SOLV
Solventum Corporation
$13B -2.5% YTD
ALGN
Align Technology, Inc.
$12B 7.7% YTD
Data is sourced from end-of-day snapshots and refreshed daily before the US market open — nothing on this page is real-time. Figures can contain vendor errors. This page is for information only and is not investment advice.